Benjamin Edwards Inc Titan Pharmaceuticals Inc Transaction History

Benjamin Edwards Inc

  • $6.71 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$1.02 - $1.93 $2 - $3
-2 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$1.87 - $2.57 $3 - $5
2 New
2 $0

Others Institutions Holding TTNP

# of Institutions
1
Shares Held
23
Call Options Held
0
Put Options Held
0
View Full List

About TITAN PHARMACEUTICALS INC

TTNP Quotes by TradingView
  • Ticker TTNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,629,200
  • Market Cap $52.8M
  • Description
  • Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...
More about TTNP
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email